Risk Factors for Intracranial Aneurysms After Radiotherapy for Head and Neck Cancer
Taxane Versus Fluorouracil: Comparing First-Line Regimens in Head and Neck Cancer
EAGLE Trial: Novel Immunotherapies for Resistant Head/Neck Cancer
Proton Therapy Versus Conventional Photon Therapy in Locally Advanced Cancer
ASCO Clinical Practice Guideline: Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
Pediatric Thyroid Cancer: 40-Year Incidence Trends in the United States
Can Preoperative Immunonutrition Improve Outcomes After Salvage Surgery for Head/Neck Cancer?
How Common Are Skin Lesions in Oral Cavity Squamous Cell Carcinoma?
Expanding Treatment Options in SCCHN: What Role Do Cancer Immunotherapies Have? (login required)
Management of Head & Neck Cancer at Disease Progression: Now What? (login required)
JADPRO Regional Lectures: Immunotherapy: Head & Neck Case Studies
Expanding Treatment Horizons in Head and Neck Cancer: TRK Inhibitors (login required)
University of Nebraska Medical Center
Huntsman Cancer Institute
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
University Hospitals Seidman Cancer Center
Cetuximab (Head and Neck Cancers)
ThyCa: Thyroid Cancer Survivors’ Association, Inc.
NCCN Guidelines for Patients®: Thyroid Cancer
Support for People with Oral and Head and Neck Cancer (SPOHNC)